Multiple sclerosis (MS) is a debilitating central nervous system (CNS) illness that attacks in early adulthood. Despite various FDA-approved drugs in the United States, multiple sclerosis therapy choices are limited. The study's major focus was on plant bioactive components, which have an essential role in the treatment of spasticity in people with Multiple Sclerosis. Many patients with MS seek out herbal therapies to assist them manage their symptoms and control their disease. According to research, 70-80% of persons with MS have tried plant products or bioactive chemicals to help them with their symptoms. Patients with MS who utilise herbal medications may provide additional study opportunities. The most often used phytotherapies are diet, omega-3 fatty acids, and antioxidants. In both relapsing and progressive types of MS, bioactive plant chemicals such as flavonoids, vitamin C, lipoic acid, and vitamin D supplementation were found to be the most promising anti-inflammatory and neuroprotective agents. Polyphenols, terpenes, alkaloids, anthocyanidine glycosides, plant amines, volatile oils, and other natural substances will all have a part in the future therapy of multiple sclerosis.
Author(S) Details
G. Neelamma
Srikrupa Institute of Pharmaceutical Sciences, Siddipet, Telangana, India.
B. Nagarani
Srikrupa Institute of Pharmaceutical Sciences, Siddipet, Telangana, India.
K. Mangamma
School of Pharmaceutical Sciences and Technologies JNTU, Kakinada, Andhra Pradesh, India.
View Book:- https://stm.bookpi.org/RDMMR-V14/article/view/4988
No comments:
Post a Comment